Treatment of glioblastoma with re-purposed renin-angiotensin system modulators: Results of a phase I clinical trial
Open Access
- 1 January 2022
- journal article
- research article
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 95, 48-54
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Metformin Downregulates the Insulin/IGF-I Signaling Pathway and Inhibits Different Uterine Serous Carcinoma (USC) Cells Proliferation and Migration in p53-Dependent or -Independent MannersPLOS ONE, 2013
- Curcumin, the Golden Spice From Indian Saffron, Is a Chemosensitizer and Radiosensitizer for Tumors and Chemoprotector and Radioprotector for Normal OrgansNutrition and Cancer, 2010
- Review: Pathobiological aspects of the local bone marrow renin-angiotensin system: a reviewJournal of the Renin-Angiotensin-Aldosterone System, 2010
- The renin-angiotensin system and malignancyCarcinogenesis, 2008
- Effects of renin-angiotensin system inhibition end-organ protection: Can we do better?Clinical Therapeutics, 2007
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human GlioblastomaCancer Research, 2004
- What are all the things that aspirin does?BMJ, 2003
- Influence of Piperine on the Pharmacokinetics of Curcumin in Animals and Human VolunteersPlanta Medica, 1998
- The Sympathetic Nervous System and Converting Enzyme InhibitionJournal of Cardiovascular Pharmacology, 1989